Selective serotonin re-uptake inhibitors and the risk of bleeding

Author： Weinrieb Robert M Auriacombe Marc Lynch Kevin G Lewis James D

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.2, 2005-03, pp. : 337-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective serotonin re-uptake inhibitors in anorexia nervosa

By Vaswani Meera Kalra Harish

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 349-357

Informa Healthcare

Access to resources Recommend Favorite

Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety

By Macdougall Mary Steiner Meir

Expert Opinion on Drug Safety, Vol. 2, Iss. 2, 2003-03 ,pp. : 161-166

Informa Healthcare

Access to resources Recommend Favorite

Overdose Risk with Selective Serotonin Reuptake Inhibitors

By Muldoon C.

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 1205-1206

Adis International

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors in Pregnancy

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4554-4561

Bentham Science Publishers

Access to resources Recommend Favorite

Current Use of Selective Serotonin Reuptake Inhibitors and Risk of Acute Myocardial Infarction

By Raymond G. Schlienger Lorenz M. Fischer

Drug Safety, Vol. 27, Iss. 14, 2004-01 ,pp. : 1157-1165

Adis International

Access to resources Recommend Favorite